Evaluation of CD10 expression as a diagnostic marker for colorectal cancer
Gastroenterology and Hepatology from Bed to Bench,
Background and aims
Adenocarcinoma is diagnosed in one out of 20 individuals in the USA and western-European countries. Its prognosis and treatment depend largely on the severity of the disease at the time of diagnosis. Additional new biological markers are being sought that can help diagnose colon cancer at an early stage. One such marker present in both serum and tumor tissue is CD10.
The concetration of CD10 were tested by ELISA and immunohistochemistry in the serum and tissue samples, respectively, from 113 patients, diagnosed histopathologically and treated for adenocarcinoma of the colon.
Additionally, ROC curve with optimal cut-off point based on Youden’s criterion was calculated for CD10.
Serum concetrations of CD10 and its tissue expression in patients diagnosed with adenocarcinoma of the colon correlate with cancer staging based on the Astler-Coller-Dukes classification.
In order to ascertain the optimal cut-off point for CD10 as a predictor of belonging to the study group, ROC curve was prepared for CD10. Optimal cut-off point for CD10 was 0.57, with prediction of belonging to the study group for CD10 ≥ 0.57.
CD10 could, therefore, be a useful marker in the early diagnosis of adenocarcinoma of the colon.
- colorectal cancer
How to Cite
2. Ellis LM, Liu W, Wilson M. Down-regulation of vascular endothelial growth factor in human colon carcinoma cell lines by antisense transfection decreases endothelial cell proliferation. Surgery 1996;5:871–8.
3. Kővári B, Báthori Á, Cserni G. CD10 Immunohistochemical expression in apocrine lesions of the breast. Pathobiology 2015;6:259–263.
4. Chu PG, Chang KL, Weiss LM, Arber DA. Immunohistochemical detection of CD10 in paraffin sections of hematopoietic neoplasms. App Imm & Mol Morphol 2000;4:257–262.
5. Ordi J, Romagosa C, Tavassoli FA, Nogales F, Palacin A, Condom E, et al. CD10 expression in epithelial tissue and tumors of the gynecologic tract. A useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors. Am J Surg Pathol 2003;2:178–186.
6. Le Gouill S, Talmant P, Touzeau C, Moreau A, Garand R, Juge-Morineau N, et al. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14:18) and 8q24/c-MYC rearrangement. Haematologica 2007;10:1335–1342.
7. Louhichi T, Saad H, Dhiab MB, Ziadi S, Trimeche M, Stromal CD10 expression in breast cancer correlates with tumor invasion and cancer stem cell phenotype. BMC Cancer 2018;49. doi: 10.1186/s12885-017–3951–8.
8. Kadota K, Buitrago D, Lee MC, Villena-Vargas J, Sima CS, Jones DR, et al. Tumoral CD10 expression correlated with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinoma. Lung Cancer 2015;3:329–336.
9. Chalcarz M, Żurawski J. Injection of Aquafilling® for Breast Augmentation Causes Inflammatory Responses Independent of Visible Symptoms. Aesthetic Plast Surg. 2020, doi: 10.1007/s00266-020-01949-y.
10. Al-Masri M, Darwazeh G, Sawalhi S, Mughrabi A, Sughayer M, Al-Shattu M. Phyllodes tumor of the breast: role of CD10 in predicting metastasis. Ann Surg Oncol 2012;4:1181–4.
11. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007;1:113–130.
12. Carl-McGrath S, Lendeckel U, Ebert M, Wolter AB, Roessner A, Röcken C. The ectopeptidases CD10, CD13, CD26, and CD143 are upregulated in gastric cancer. Int J Oncol 2004;5:1223–1232.
13. Ganju RK, Sunday M, Tsarwhas DG, Shipp MA. CD10/NEP in non–small cell lung carcinomas. Relationship to cellular proliferation. J Clin Invest 1994;5;1784–1791.
14. Langner C, Ratschek M, Rehak P, Schips L, Zigeuner R. CD10 is a diagnostic and prognostic marker in renal malignancies. Histopathology 2004;5:460–7.
15. Tawfic S, Niehans GA, Manivel JC. The pattern of CD10 expression in selected pathologic entities of the prostate gland. Hum Pathol 2003;5:450-456.
16. Sato Y, Itoh F, Hinoda Y, Ohe Y, Nakagawa N, Ueda R, et al. Expression of CD10/neutral endopeptidase in normal and malignant tissues of the human stomach and colon. J Gastroenterol 1996;1:12–17.
17. Groisman GM, Amar M, Livne E. CD10: a valuable tool for the light microscopic diagnosis of microvillous inclusion disease (familial microvillous atrophy). Am J Surg Pathol 2002;7:902–7.
18. Lloyd JM, Owens SR. CD10 immunohistochemistry stains enteric mucosa, but negative staining is unreliable in the setting of active enteritis. Mod Pathol 2011;12:1627–1632.
19. Jang TJ, Park JB, Lee JI. The expression of cd10 and cd15 is progressively increased during colorectal cancer development. Korean J Pathol 2013;4:340–347.
20. Ogawa H, Iwaya K, Izumi M, Kuroda M, Serizawa H, KoyonagiY, Mukai K. Expression of CD10 by stromal cells during colorectal tumor development. Hum Pathol 2002;8:806–811.
21. Iwaya K, Ogawa H, Izumi M, Kuroda M, Mukai K. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome. Virchows Arch 2002;6:589–593.
- Abstract Viewed: 0 times
- pdf Downloaded: 0 times